• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Human Normal Immunoglobulin
    8 Drugs classified under this active ingredient

    All the Active Ingredient Drugs

    Filter by letter: ALL A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
    Beriglobin P
    partial basket chart
    Beriglobin P

    Immunoglobulins. Human Normal Immunoglobulin 160 mg/ml.
    PFS: 1 x 2 cc, 5 cc. See lit.
    Defic. defect. antibody synth., protracted
    transitory hypogammaglobulem.,
    proph. hepatit. A, measles or attenuat.
    C/I: Severe thrombocytopen., other
    coag. disords., isolated immunoglobulin
    A (IgA) defic.

    partial basket chart

    Human Normal Immunoglobulin 5 g/100 ml.
    VIALS: 1 x 2.5 g/50 ml, 5 g/100 ml, 10
    g/200 ml. Dose depend. indicat. and
    pharmacokinetic/clinic. response. See lit.
    Replace. ther. in: Prim. immunodefic.
    (congen. agammaglobulinem.,
    hypogammaglobulinem., common
    variable immunodefic.); Wiskott Aldrich
    syndr. Myeloma/chron. lymphocytic leuk.
    with severe second.
    hypogammaglobulinem and recurr.
    infects. Child with congen. AIDS and
    recurr. infects.
    C/I: Hypersens. See lit.

    Gamunex C
    partial basket chart
    Gamunex C

    Human Normal Immunoglobulin 0.1 gr/ml.
    VIAL: 1 x 10 ml, 25 ml, 50 ml, 100 ml.
    See lit.
    Prim. immunodefic. (PI), idiopath.
    thrombocytopen. purpura (ITP). Chron.
    inflamm. demyelinat. polyneuropath.
    C/I: Known anaphylact./severe system.
    response to human immunoglob.,
    severe select. IgA defic. See lit.

    partial basket chart

    Human Normal Immunoglobulin 50 mg/ml, 100 mg/ml.
    VIAL: 1 x 20 ml, 50 ml, 100 ml, 250 ml.
    Infus. I.V. at initial rate of not more than 1.4 ml/kg/hr for 30 mins. May incr.
    to max. 1.9 ml/kg/hr. Replacement
    ther./infects & proph. graft. vs. host dis:
    Individ. for ea. pt. See lit.
    Replace. ther. in prim. immunodefic. synrs.
    (congen. agammaglobulinem.,
    hypogammaglobulinem.), common
    variable/severe comb. immunodefic.
    Wiskott Aldrich syndr. Myeloma, chron.
    lymph. leuk. with severe second.
    hypogammaglobulinem. & recur. infects.
    Child with AIDS & recur. infects., ITP, Guillain
    Barré syndr., Kawasaki dis., allogen. bone
    marrow transplant.
    C/I: Hypersens.

    partial basket chart

    Human Normal Immunoglobulin 100 mg/ml.
    VIAL (sol. for infus.): 1 x 10, 25, 50, 100,
    200, 300 ml. See lit.
    Replace. ther. in : Prim. immunodefic
    syndrs. with impaired antibody product.,
    hypogammaglobulinem., recurr. bact.
    infects. with chron. lymphoc. leukem. in
    whom prophylact. antibiotics failed,
    hypogammaglobulinem. and recurr.
    bact. infects in plateau phase multiple
    myeloma with failed response to
    pneumococc. imunizat., child and
    adolesc. (0-18 yrs) with congen. AIDS and
    recurr. bact. infects.,
    hypogammaglobulinem. aft. allogen.
    hematopoiet. stem cell transplant.
    (HSCT). Immunomodulat: Primary
    immune thrombocytopenia (ITP), in high
    risk of bleed/prior to surg. to correct
    platelet count. Guillain Barre syndr.,
    Kawasaki dis.
    Hypersens. to product., to human
    immunoglobulins. See lit.

    not in the basket chart
    Multiple ingredients

    Cytomegalovirus Antibody 100 IU/ml, Human Plasma Protein 50 mg/ml, Human Normal Immunoglobulin 96%.
    AMPS: 5 ml (250 U); 10 ml (500 U); 20 ml
    (1,000 U).
    INFUS: 50 ml (2,500U). 50 U/kg bdy. wt.
    on 1st day of transplant or day prior
    (bone marrow transplant), by I.V. infus.
    or inject. See lit.
    Proph. cytomegalovirus infect. in pts.
    subjected to immunosuppress. ther.
    (partic. in transplant pts.)
    C/I: Intol. to homologous
    immunoglobulins. See lit.